1. Home
  2. FTRA vs EIKN Comparison

FTRA vs EIKN Comparison

Compare FTRA & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTRA

FutureCorp Space Acquisition 1 Class A Ordinary Shares

SELL

Current Price

$9.88

Market Cap

283.5M

Sector

N/A

ML Signal

SELL

Logo Eikon Therapeutics Inc. Common Stock

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$4.80

Market Cap

316.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTRA
EIKN
Founded
2026
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.5M
316.3M
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
FTRA
EIKN
Price
$9.88
$4.80
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $24.00
AVG Volume (30 Days)
65.9K
★ 511.7K
Earning Date
N/A
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$4.72
52 Week High
$10.23
$16.50

Technical Indicators

Market Signals
Indicator
FTRA
EIKN
Relative Strength Index (RSI) 52.26 33.10
Support Level $9.85 N/A
Resistance Level $9.95 $6.82
Average True Range (ATR) 0.03 0.63
MACD 0.00 -0.04
Stochastic Oscillator 7.89 3.10

Price Performance

Historical Comparison
FTRA
EIKN

About FTRA FutureCorp Space Acquisition 1 Class A Ordinary Shares

FutureCorp Space Acquisition 1 is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.

About EIKN Eikon Therapeutics Inc. Common Stock

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Share on Social Networks: